The Burden of Heart Failure in the US: Medical Costs and Health-Related Quality of Life
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background
To quantify the economic burden and health-related quality of life (HRQoL) impact of heart failure (HF) in the U.S., stratified by age and diabetes status.
Methods
Using a micro-level, bottom-up prevalence-based approach from a payer perspective, we analyzed healthcare costs from the Optum Research Database (ORD). HF prevalence and HRQoL via EuroQol 5-Dimensions and Healthy Days instruments were estimated using National Health and Nutrition Examination Survey (NHANES).
Results
The average annual direct healthcare cost per HF patient was approximately $31,464 at baseline, rising to $45,893 in the first-year post-diagnosis before stabilizing around $37,500 annually. Inpatient care accounted for the largest cost share. Extrapolating at the national level, expenditures exceeded $227 billion at baseline and peaked at $332 billion in the year following a HF hospitalization. Individuals without diabetes had the highest quality-adjusted life years (QALYs) and lowest costs, while type 1 diabetes patients had the lowest QALYs and highest costs. Type 2 diabetes patients represented the largest subgroup with intermediate QALYs but substantial costs.
Conclusions
HF imposes a significant, sustained economic and quality-of-life burden, highlighting the need for targeted management strategies, especially for older adults and those with diabetes.
